Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -2.52%

Clover Health Investments, Corp. EBITDA Margin is -2.52% for the Trailing 12 Months (TTM) ending June 30, 2025, a -67.34% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -7.73%, a -30.02% change year over year.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -11.04%, a -28.35% change year over year.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -15.41%, a -66.24% change year over year.
  • Clover Health Investments, Corp. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -45.64%.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin